A Real-world Pharmacovigilance Study Of FDA Adverse Event Reporting System (FAERS) Events For Gender Of Voriconazole Drugs
Drug Research · 01.07.2025 · 75 (06) · 218-224
DOI: 10.1055/a-2575-1530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2025. Verfasst von Qiong Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Unive…. Hauptthemen laut MEDLINE: Voriconazole, Adverse Drug Reaction Reporting Systems, Pharmacovigilance, Antifungal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
To detect the gender variations in adverse events (AEs) of voriconazole, promote personalised medicine. A normalized dataset from Q1 2004 to Q4 2022 from the US Food and Drug Administrationʼs Adverse Event Reporting System (FAERS) was analyses. The reporting odds ratio (ROR), proportional reporting ratio (PRR), and P value were used to examine data from the FAERS database to detect risk signals and quantify the presence and extent of gender variations in voriconazole adverse events. A total of 7670 cases (female/male (2785/4885)) of adverse reactions to voriconazole were analysed, and drug interaction (ROR 1.30 (1.10,1.54)), death and sudden death (ROR 1.31 (1.06,1.61)), actinic keratosis (ROR 1.98 (1.10,3.57)) were found to be significantly more frequent in male patients than in female patients. We found that gender was a determinant in voriconazole-related AEs using FAERS. Our results require future validation due to the inherent limits of this open data source, but they also identify potential contributing elements for a customised side effect profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
- Department of Orthopedics, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Zitieren
APA
Xu, Q., Cheng, H., Sun, X., Zhao, J., Chen, Y., Ji, L., & Liang, Y. (2025). A Real-world Pharmacovigilance Study Of FDA Adverse Event Reporting System (FAERS) Events For Gender Of Voriconazole Drugs. Drug Research, 75(06), 218-224. https://doi.org/10.1055/a-2575-1530
Vancouver
Xu Q, Cheng H, Sun X, Zhao J, Chen Y, Ji L, et al. A Real-world Pharmacovigilance Study Of FDA Adverse Event Reporting System (FAERS) Events For Gender Of Voriconazole Drugs. Drug Research. 2025;75(06):218-224. doi:10.1055/a-2575-1530
BibTeX
@article{Xu2025,
author = {Xu, Qiong and Cheng, Hongxia and Sun, Xu and Zhao, Jing and Chen, Yingying and Ji, Lingyu and Liang, Yan},
title = {A Real-world Pharmacovigilance Study Of FDA Adverse Event Reporting System (FAERS) Events For Gender Of Voriconazole Drugs},
journal = {Drug Research},
year = {2025},
volume = {75},
number = {06},
pages = {218--224},
doi = {10.1055/a-2575-1530}
}
EUVIMED